Focused Wealth Management, Inc - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q1 2018$1,0000.0%9,2500.0%0.00%
Q4 2017$1,0009,250
-24.2%
0.00%
Q2 2017$0
-100.0%
12,2050.0%0.00%
Q1 2017$1,00012,205
+313.0%
0.00%
Q4 2016$02,9550.0%0.00%
Q3 2016$0
-100.0%
2,9550.0%0.00%
Q2 2016$1,0000.0%2,9550.0%0.00%
-100.0%
Q1 2016$1,0000.0%2,9550.0%0.00%0.0%
Q4 2015$1,000
-50.0%
2,9550.0%0.00%0.0%
Q3 2015$2,0000.0%2,9550.0%0.00%0.0%
Q2 2015$2,0000.0%2,955
+34.0%
0.00%0.0%
Q1 2015$2,000
+100.0%
2,205
+29.3%
0.00%0.0%
Q4 2014$1,0001,7050.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2016
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders